CIMB sees a confluence of positive triggers in the pharma space and has initiated coverage on the entire sector. The brokerage house believes that improving US outlook and strong domestic businesses will lead to healthy cash flows and better RoEs.
CIMB is overweight on stocks like Dr Reddy’s Laboratories (DRL), Cadila Healthcare, Cipla, Alkem Laboratories, Natco Pharma, Ajanta Pharma and Indigo Pharma. The brokerage has a hold rating on stocks like Alembic and Torrent Pharma.
Watch the video for more
To watch other videos in this series, click on the Standout Brokerage Report tab below